{"id":"https://openalex.org/W2010843246","doi":"https://doi.org/10.1016/j.antiviral.2009.02.206","title":"New peptidomimetic prodrugs of acyclic and cyclic cidofovir: sar studies of chemical and enzymatic activation mechanisms","display_name":"New peptidomimetic prodrugs of acyclic and cyclic cidofovir: sar studies of chemical and enzymatic activation mechanisms","publication_year":2009,"publication_date":"2009-05-01","ids":{"openalex":"https://openalex.org/W2010843246","doi":"https://doi.org/10.1016/j.antiviral.2009.02.206","mag":"2010843246"},"language":"en","primary_location":{"id":"doi:10.1016/j.antiviral.2009.02.206","doi":"https://doi.org/10.1016/j.antiviral.2009.02.206","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.antiviral.2009.02.206","pdf_url":null,"source":{"id":"https://openalex.org/S137372404","display_name":"Antiviral Research","issn_l":"0166-3542","issn":["0166-3542","1872-9096"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antiviral Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5011933351","display_name":"Charles E. McKenna","orcid":"https://orcid.org/0000-0002-3540-6663","observed_orcids":["https://orcid.org/0000-0002-3540-6663"]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Charles E. McKenna","raw_affiliation_strings":["Department of Chemistry, University of Southern California, Los Angeles, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, University of Southern California, Los Angeles, CA, United States","institution_ids":["https://openalex.org/I1174212"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063169488","display_name":"Larryn W. Peterson","orcid":"https://orcid.org/0000-0003-4448-9154","observed_orcids":["https://orcid.org/0000-0003-4448-9154"]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Larryn W. Peterson","raw_affiliation_strings":["Department of Chemistry, University of Southern California, Los Angeles, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, University of Southern California, Los Angeles, CA, United States","institution_ids":["https://openalex.org/I1174212"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041489306","display_name":"B. A. Kashemirov","orcid":"https://orcid.org/0000-0001-7175-9960","observed_orcids":["https://orcid.org/0000-0001-7175-9960"]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Boris A. Kashemirov","raw_affiliation_strings":["Department of Chemistry, University of Southern California, Los Angeles, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, University of Southern California, Los Angeles, CA, United States","institution_ids":["https://openalex.org/I1174212"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003417223","display_name":"Michaela Serpi","orcid":"https://orcid.org/0000-0002-6162-7910","observed_orcids":["https://orcid.org/0000-0002-6162-7910"]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michaela Serpi","raw_affiliation_strings":["Department of Chemistry, University of Southern California, Los Angeles, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, University of Southern California, Los Angeles, CA, United States","institution_ids":["https://openalex.org/I1174212"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035949118","display_name":"Stefanie Mitchell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210127861","display_name":"Therapeutics Systems Research Laboratories (United States)","ror":"https://ror.org/03hbd7c15","country_code":"US","type":"company","lineage":["https://openalex.org/I4210127861"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stefanie Mitchell","raw_affiliation_strings":["TSRL, Inc., Ann Arbor, MI, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"TSRL, Inc., Ann Arbor, MI, United States","institution_ids":["https://openalex.org/I4210127861"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064459397","display_name":"Jae Seung Kim","orcid":"https://orcid.org/0000-0003-1710-1185","observed_orcids":["https://orcid.org/0000-0003-1710-1185"]},"institutions":[{"id":"https://openalex.org/I4210127861","display_name":"Therapeutics Systems Research Laboratories (United States)","ror":"https://ror.org/03hbd7c15","country_code":"US","type":"company","lineage":["https://openalex.org/I4210127861"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jae Seung Kim","raw_affiliation_strings":["TSRL, Inc., Ann Arbor, MI, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"TSRL, Inc., Ann Arbor, MI, United States","institution_ids":["https://openalex.org/I4210127861"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112712077","display_name":"John M. Hilfinger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210127861","display_name":"Therapeutics Systems Research Laboratories (United States)","ror":"https://ror.org/03hbd7c15","country_code":"US","type":"company","lineage":["https://openalex.org/I4210127861"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John M. Hilfinger","raw_affiliation_strings":["TSRL, Inc., Ann Arbor, MI, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"TSRL, Inc., Ann Arbor, MI, United States","institution_ids":["https://openalex.org/I4210127861"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110073621","display_name":"John C. Drach","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John C. Drach","raw_affiliation_strings":["College of Pharmacy University of Michigan, Ann Arbor, MI, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"College of Pharmacy University of Michigan, Ann Arbor, MI, United States","institution_ids":["https://openalex.org/I27837315"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4160,"currency":"USD","value_usd":4160},"apc_paid":null,"fwci":0.9154,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.7571406,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"82","issue":"2","first_page":"A75","last_page":"A75"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.5449000000953674,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.5449000000953674,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10625","display_name":"Herpesvirus Infections and Treatments","score":0.2029999941587448,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10911","display_name":"Chemical Synthesis and Analysis","score":0.029400000348687172,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cidofovir","display_name":"cidofovir","score":0.9599999785423279},{"id":"https://openalex.org/keywords/prodrugs","display_name":"prodrugs","score":0.7639999985694885},{"id":"https://openalex.org/keywords/peptidomimetics","display_name":"peptidomimetics","score":0.921999990940094},{"id":"https://openalex.org/keywords/acyclic-nucleosides","display_name":"acyclic nucleosides","score":0.7889999747276306},{"id":"https://openalex.org/keywords/chemical-activation","display_name":"chemical activation","score":0.7039999961853027},{"id":"https://openalex.org/keywords/enzyme-activation","display_name":"enzyme activation","score":0.9520000219345093},{"id":"https://openalex.org/keywords/antiviral-nucleoside-analogues","display_name":"antiviral nucleosides","score":0.5690000057220459}],"concepts":[{"id":"https://openalex.org/C108215921","wikidata":"https://www.wikidata.org/wiki/Q603741","display_name":"Prodrug","level":2,"score":0.9013032913208008},{"id":"https://openalex.org/C124790011","wikidata":"https://www.wikidata.org/wiki/Q2069797","display_name":"Peptidomimetic","level":3,"score":0.8258053064346313},{"id":"https://openalex.org/C2776824251","wikidata":"https://www.wikidata.org/wiki/Q423445","display_name":"Cidofovir","level":3,"score":0.6604414582252502},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.5830009579658508},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.578254222869873},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.49132004380226135},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.4002937078475952},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3715476393699646},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.29565221071243286},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2110426127910614},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.11854532361030579},{"id":"https://openalex.org/C2779281246","wikidata":"https://www.wikidata.org/wiki/Q172847","display_name":"Peptide","level":2,"score":0.06266412138938904},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.antiviral.2009.02.206","doi":"https://doi.org/10.1016/j.antiviral.2009.02.206","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.antiviral.2009.02.206","pdf_url":null,"source":{"id":"https://openalex.org/S137372404","display_name":"Antiviral Research","issn_l":"0166-3542","issn":["0166-3542","1872-9096"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antiviral Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.46810001134872437}],"sustainable_development_goals_aurora":[{"display_name":"Zero hunger","id":"https://metadata.un.org/sdg/2","score":0.46000000834465027}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2302069667","https://openalex.org/W6889357304","https://openalex.org/W1977940485","https://openalex.org/W2076781598","https://openalex.org/W2017981741","https://openalex.org/W2054649126","https://openalex.org/W4256661946","https://openalex.org/W2365644059","https://openalex.org/W2056699241","https://openalex.org/W1986556907"],"abstract_inverted_index":null,"counts_by_year":[{"year":2013,"cited_by_count":1}],"updated_date":"2026-08-21T09:56:20.448147","created_date":"2016-06-24T00:00:00"}